000874374 001__ 874374
000874374 005__ 20220930130232.0
000874374 0247_ $$2doi$$a10.1093/braincomms/fcaa022
000874374 0247_ $$2Handle$$a2128/25180
000874374 0247_ $$2altmetric$$aaltmetric:77082527
000874374 0247_ $$2pmid$$apmid:32954283
000874374 0247_ $$2WOS$$aWOS:000574931600022
000874374 037__ $$aFZJ-2020-01396
000874374 082__ $$a610
000874374 1001_ $$0P:(DE-Juel1)156374$$aKovermann, Peter$$b0$$eCorresponding author$$ufzj
000874374 245__ $$aIncreased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6
000874374 260__ $$a[Großbritannien]$$bGuarantors of Brain$$c2020
000874374 3367_ $$2DRIVER$$aarticle
000874374 3367_ $$2DataCite$$aOutput Types/Journal article
000874374 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1594793219_5409
000874374 3367_ $$2BibTeX$$aARTICLE
000874374 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000874374 3367_ $$00$$2EndNote$$aJournal Article
000874374 520__ $$aEpisodic ataxia type 6 is an inherited neurological condition characterized by combined ataxia and epilepsy. A severe form of this disease with episodes combining ataxia, epilepsy and hemiplegia was recently associated with a proline to arginine substitution at position 290 of the excitatory amino acid transporter 1 in a heterozygous patient. The excitatory amino acid transporter 1 is the predominant glial glutamate transporter in the cerebellum. However, this glutamate transporter also functions as an anion channel and earlier work in heterologous expression systems demonstrated that the mutation impairs the glutamate transport rate, while increasing channel activity. To understand how these changes cause ataxia, we developed a constitutive transgenic mouse model. Transgenic mice display epilepsy, ataxia and cerebellar atrophy and, thus, closely resemble the human disease. We observed increased glutamate-activated chloride efflux in Bergmann glia that triggers the apoptosis of these cells during infancy. The loss of Bergmann glia results in reduced glutamate uptake and impaired neural network formation in the cerebellar cortex. This study shows how gain-of-function of glutamate transporter-associated anion channels causes ataxia through modifying cerebellar development.
000874374 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000874374 588__ $$aDataset connected to CrossRef
000874374 7001_ $$0P:(DE-Juel1)156548$$aUntiet, Verena$$b1
000874374 7001_ $$0P:(DE-Juel1)171438$$aKolobkova, Yulia$$b2$$ufzj
000874374 7001_ $$0P:(DE-Juel1)171198$$aEngels, Miriam$$b3$$ufzj
000874374 7001_ $$0P:(DE-HGF)0$$aBaader, Stephan$$b4
000874374 7001_ $$0P:(DE-HGF)0$$aSchilling, Karl$$b5
000874374 7001_ $$0P:(DE-Juel1)136837$$aFahlke, Christoph$$b6$$ufzj
000874374 773__ $$0PERI:(DE-600)3020013-1$$a10.1093/braincomms/fcaa022$$gp. fcaa022$$n1$$pfcaa022$$tBrain communications$$v2$$x2632-1297$$y2020
000874374 8564_ $$uhttps://juser.fz-juelich.de/record/874374/files/Invoice_E13679252.pdf
000874374 8564_ $$uhttps://juser.fz-juelich.de/record/874374/files/Final%20Draft%20Post%20Referee.pdf$$yOpenAccess
000874374 8564_ $$uhttps://juser.fz-juelich.de/record/874374/files/fcaa022.pdf$$yOpenAccess
000874374 8564_ $$uhttps://juser.fz-juelich.de/record/874374/files/Final%20Draft%20Post%20Referee.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000874374 8564_ $$uhttps://juser.fz-juelich.de/record/874374/files/fcaa022.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000874374 8767_ $$8E13679252$$92020-05-27$$d2020-07-16$$eAPC$$jZahlung erfolgt$$pfcaa022$$zBelegnummer: 1200154859
000874374 909CO $$ooai:juser.fz-juelich.de:874374$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000874374 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156374$$aForschungszentrum Jülich$$b0$$kFZJ
000874374 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)171438$$aForschungszentrum Jülich$$b2$$kFZJ
000874374 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)171198$$aForschungszentrum Jülich$$b3$$kFZJ
000874374 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)136837$$aForschungszentrum Jülich$$b6$$kFZJ
000874374 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000874374 9141_ $$y2020
000874374 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000874374 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000874374 920__ $$lyes
000874374 9201_ $$0I:(DE-Juel1)ICS-4-20110106$$kICS-4$$lZelluläre Biophysik$$x0
000874374 980__ $$ajournal
000874374 980__ $$aVDB
000874374 980__ $$aI:(DE-Juel1)ICS-4-20110106
000874374 980__ $$aAPC
000874374 980__ $$aUNRESTRICTED
000874374 9801_ $$aAPC
000874374 9801_ $$aFullTexts
000874374 981__ $$aI:(DE-Juel1)IBI-1-20200312